DK1982696T3 - Gel til behandling af sår - Google Patents

Gel til behandling af sår

Info

Publication number
DK1982696T3
DK1982696T3 DK07007981.9T DK07007981T DK1982696T3 DK 1982696 T3 DK1982696 T3 DK 1982696T3 DK 07007981 T DK07007981 T DK 07007981T DK 1982696 T3 DK1982696 T3 DK 1982696T3
Authority
DK
Denmark
Prior art keywords
gel
wounds
treatment
production
antiseptic
Prior art date
Application number
DK07007981.9T
Other languages
English (en)
Inventor
Christoph Abels
Ulrich Knie
Der Hoeh Annette Von
Original Assignee
August Wolff Gmbh & Co Kg Arzn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by August Wolff Gmbh & Co Kg Arzn filed Critical August Wolff Gmbh & Co Kg Arzn
Application granted granted Critical
Publication of DK1982696T3 publication Critical patent/DK1982696T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK07007981.9T 2007-04-19 2007-04-19 Gel til behandling af sår DK1982696T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07007981A EP1982696B1 (de) 2007-04-19 2007-04-19 Gel zur Behandlung von Wunden

Publications (1)

Publication Number Publication Date
DK1982696T3 true DK1982696T3 (da) 2010-07-26

Family

ID=38330212

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07007981.9T DK1982696T3 (da) 2007-04-19 2007-04-19 Gel til behandling af sår

Country Status (5)

Country Link
EP (1) EP1982696B1 (da)
AT (1) ATE468106T1 (da)
DE (1) DE502007003850D1 (da)
DK (1) DK1982696T3 (da)
ES (1) ES2343208T3 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2487773B (en) * 2011-02-04 2014-09-17 Aidance Skincare & Topical Solutions Llc Topical antibiotic formulations
DE102009049504A1 (de) 2009-10-15 2011-04-21 Schülke & Mayr GmbH Wund- und Schleimhautantiseptikum auf der Basis von Bispyridiniumalkanen
DE102010025932A1 (de) 2010-07-02 2012-01-05 Schülke & Mayr GmbH Antiseptikum auf der Basis von Bispyridiniumalkanen
RU2426525C1 (ru) * 2010-08-31 2011-08-20 Закрытое акционерное общество "Институт прикладной нанотехнологии" Профилактическая мазь для диабетической стопы
US20130017227A1 (en) * 2011-07-15 2013-01-17 Lambert Jr Cary Jake Wound healing compositions and associated methods
DE102012001216A1 (de) * 2012-01-22 2013-07-25 Stefan Margraf Verfahren und Applikator zur perioperativen Desinfektion von durch nicht natürliche Öffnungen einzuführenden medizinischen Instrumenten
DE102012007212A1 (de) 2012-04-11 2013-10-17 Merz Pharma Gmbh & Co. Kgaa Zubereitung zur topischen Anwendung auf Schleimhäuten mit Polyhexanid als Wirkstoff
ITRM20130673A1 (it) * 2013-12-05 2015-06-06 Welcare Ind S P A Composizioni per uso nel trattamento delle lesioni cutanee
EP2896396A1 (en) 2014-01-20 2015-07-22 Abem Kimya Tibbi Malzemeler Yönetim Danismanligi Temizlik Servis Hizmetleri Sanayi Ve Dis Ticaret Limited Sirketi Herbal formulation for topical wound treatment
EP3111958A1 (en) 2015-06-30 2017-01-04 Pharmbridge Sp. z o.o. Supramolecular aggregate composed of phosphatidylocholinea and octenidine, compositions comprising (containing) it and metod for obtaining thereof
US12090205B2 (en) * 2019-10-28 2024-09-17 Rochal Technologies Llc Poloxamer compositions with reduced sol-gel transition temperatures and methods of reducing the sol-gel transition temperature of poloxamer compositions
CN110917339B (zh) * 2019-12-27 2023-07-07 遵义医学院附属医院 一种溶葡萄球菌酶凝胶剂及其在mrsa感染创面中的应用
WO2024226871A1 (en) * 2023-04-27 2024-10-31 Mccord Darlene E Compositions and methods of dissolving biofilm to promote wound healing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585575B1 (fr) * 1985-08-01 1989-03-03 Pf Medicament Compositions pharmaceutiques a activite keratolytique sous forme de gel comportant de l'acide salicylique hydro-alcoolique
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
CN1106259A (zh) * 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
GB2362100B (en) * 2000-05-08 2002-05-08 Maelor Pharmaceuticals Ltd Wound gels
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use

Also Published As

Publication number Publication date
EP1982696B1 (de) 2010-05-19
DE502007003850D1 (de) 2010-07-01
ES2343208T3 (es) 2010-07-26
EP1982696A1 (de) 2008-10-22
ATE468106T1 (de) 2010-06-15

Similar Documents

Publication Publication Date Title
DE502007003850D1 (de) Gel zur Behandlung von Wunden
FR2927254B1 (fr) Utilisation de substances actives naturelles dans des compositions cosmetiques ou therapeutiques
CL2015003188A1 (es) Divisional de la solicitud 578-2014 por composición controladora de enfermedades en plantas y métodos para controlar enfermedades en plantas
PH12019501469A1 (en) Compositions and methods for treating biofilms
IL249263B (en) Method for ex-vivo organ care
EP2144590A4 (en) SKIN TREATMENT COMPOSITIONS AND METHODS
EP2349279A4 (en) MODIFIERS OF ALDEHYDE DEHYDROGENASE AND METHODS OF USE THEREOF
EA201290988A1 (ru) Стереоселективный синтез фосфорсодержащих активных соединений
CR11731A (es) Composiciones y procedimientos para su preparación y uso
AR093386A1 (es) Composicion para tratar la diabetes o la diabesidad que comprende un analogo de oxintomodulina y metodo de tratamiento
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
EA201070447A1 (ru) Способ обработки волос
CO6470893A2 (es) Agente y método de control para podredumbre blanda
RU2009118942A (ru) Способ стимуляции регенерации тканей
CO6390030A2 (es) Sellador de teta intramamario
AR080816A1 (es) Preparacion derivada de un cultivo in vitro de celulas de argan no evocadas desdiferenciadas, su uso para el tratamiento del envejecimiento, la inflamacion y curacion de la piel, y metodo para su obtencion
NI201000015A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
UY33276A (es) Compuestos de amino-oxazinas y amino-dihidrotiazina como moduladores de beta-secretasa y métodos de uso
EA200970154A1 (ru) Косметические или дерматологические препараты, содержащие n-ацетилцистеин
MX2024012898A (es) Proteinas de fusion de enzimas lisosomales terapeuticas dirigidas, formulaciones asociadas y usos de las mismas
CO6351683A2 (es) Agente de tratamiento de semillas y metodo para proteger plantas
ATE536894T1 (de) Filmbildende gelkomposition zur wund- bzw. hauptpflege
UA110332C2 (en) Use of 2,3-dihydroxypropyldodecanoate for treatment of seborrhea
PT1572178E (pt) Tratamento de mastalgia com 4-hidroxi-tamoxifeno
CL2009000065A1 (es) Proteina aislada que comprende una pluralidad de dominios rrl para utilizarse como agente anti-microbiano; composicion farmaceutica que comprende dicha proteina aislada; metodo para tratar infeccion microbiana.